Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression.

Soriano-Sarabia N, Vallejo A, Ramírez-Lorca R, Rodríguez Mdel M, Salinas A, Pulido I, Sáez ME, Leal M.

J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):128-35. doi: 10.1097/QAI.0b013e318184fb41.

PMID:
18769358
2.

Association of single-nucleotide polymorphisms in TLR7 (Gln11Leu) and TLR9 (1635A/G) with a higher CD4T cell count during HIV infection.

Said EA, Al-Yafei F, Zadjali F, Hasson SS, Al-Balushi MS, Al-Mahruqi S, Koh CY, Al-Naamani K, Al-Busaidi JZ, Idris MA, Balkhair A, Al-Jabri AA.

Immunol Lett. 2014 Jul;160(1):58-64. doi: 10.1016/j.imlet.2014.04.005. Epub 2014 Apr 16.

PMID:
24747071
3.

Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.

Pine SO, McElrath MJ, Bochud PY.

AIDS. 2009 Nov 27;23(18):2387-95. doi: 10.1097/QAD.0b013e328330b489.

4.

TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.

Hong J, Leung E, Fraser AG, Merriman TR, Vishnu P, Krissansen GW.

J Gastroenterol Hepatol. 2007 Nov;22(11):1760-6.

PMID:
17914947
5.

Association of toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms with increased infection risk in patients with advanced HIV-1 infection.

Papadopoulos AI, Ferwerda B, Antoniadou A, Sakka V, Galani L, Kavatha D, Panagopoulos P, Poulakou G, Kanellakopoulou K, van der Meer JW, Giamarellos-Bourboulis EJ, Netea MG.

Clin Infect Dis. 2010 Jul 15;51(2):242-7. doi: 10.1086/653607.

PMID:
20521908
6.

A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression.

Oh DY, Baumann K, Hamouda O, Eckert JK, Neumann K, Kücherer C, Bartmeyer B, Poggensee G, Oh N, Pruss A, Jessen H, Schumann RR.

AIDS. 2009 Jan 28;23(3):297-307. doi: 10.1097/QAD.0b013e32831fb540.

PMID:
19114863
7.

TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients.

Joshi A, Punke EB, Mehmetoglu-Gurbuz T, Peralta DP, Garg H.

BMC Infect Dis. 2019 Jan 16;19(1):56. doi: 10.1186/s12879-019-3697-9.

8.

Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection.

Bochud PY, Hersberger M, Taffé P, Bochud M, Stein CM, Rodrigues SD, Calandra T, Francioli P, Telenti A, Speck RF, Aderem A; Swiss HIV Cohort Study.

AIDS. 2007 Feb 19;21(4):441-6.

PMID:
17301562
9.

Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects.

Viladés C, Broch M, Plana M, Domingo P, Alonso-Villaverde C, Pedrol E, Knobel H, Dalmau D, Peraire J, Gutiérrez C, López A, Sambeat MA, Olona M, Garcia F, Richart C, Gatell JM, Vidal F; Chemokines and Long-Term Nonprogressors Study Group.

J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):132-8.

PMID:
17091019
10.

Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children.

Freguja R, Gianesin K, Del Bianco P, Malacrida S, Rampon O, Zanchetta M, Giaquinto C, De Rossi A.

AIDS. 2012 Mar 27;26(6):765-8. doi: 10.1097/QAD.0b013e3283514350.

PMID:
22269973
11.

Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus.

Eid AJ, Brown RA, Paya CV, Razonable RR.

Transplantation. 2007 Aug 27;84(4):511-6.

PMID:
17713436
12.

Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation.

Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR.

Clin Infect Dis. 2007 May 15;44(10):1315-20. Epub 2007 Apr 11.

PMID:
17443468
13.

Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection.

Lester RT, Yao XD, Ball TB, McKinnon LR, Kaul R, Wachihi C, Jaoko W, Plummer FA, Rosenthal KL.

AIDS. 2008 Mar 30;22(6):685-94. doi: 10.1097/QAD.0b013e3282f4de35.

PMID:
18356597
14.

Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females.

Wichukchinda N, Nakayama EE, Rojanawiwat A, Pathipvanich P, Auwanit W, Vongsheree S, Ariyoshi K, Sawanpanyalert P, Shioda T.

AIDS. 2006 Jan 9;20(2):189-96.

PMID:
16511411
15.

Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis.

Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW, Rodrigues F.

J Infect Dis. 2008 Feb 15;197(4):618-21. doi: 10.1086/526500.

PMID:
18275280
16.

Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women.

Wujcicka W, Paradowska E, Studzińska M, Wilczyński J, Nowakowska D.

Virol J. 2017 Mar 24;14(1):64. doi: 10.1186/s12985-017-0730-8.

17.

Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation.

Carvalho A, Cunha C, Carotti A, Aloisi T, Guarrera O, Di Ianni M, Falzetti F, Bistoni F, Aversa F, Pitzurra L, Rodrigues F, Romani L.

Exp Hematol. 2009 Sep;37(9):1022-9. doi: 10.1016/j.exphem.2009.06.004. Epub 2009 Jun 17.

PMID:
19539691
18.

Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.

Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.

Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.

19.

Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load.

Singh KK, Hughes MD, Chen J, Spector SA.

J Infect Dis. 2005 Jun 1;191(11):1971-80. Epub 2005 Apr 28.

PMID:
15871132
20.

Genetic variants in toll-like receptor 2 (TLR2), TLR4, TLR9, and FCγ receptor II are associated with antibody response to quadrivalent meningococcal conjugate vaccine in HIV-infected youth.

Spector SA, Qin M, Lujan-Zilbermann J, Singh KK, Warshaw MG, Williams PL, Jean-Philippe P, Fenton T, Siberry GK; IMPAACT P1065 Protocol Team.

Clin Vaccine Immunol. 2013 Jun;20(6):900-6. doi: 10.1128/CVI.00042-13. Epub 2013 Apr 17.

Supplemental Content

Support Center